The risk of cardiac events in patients receiving immune checkpoint inhibitors: a nationwide Danish study.

MLA

D’Souza, Maria, et al. “The Risk of Cardiac Events in Patients Receiving Immune Checkpoint Inhibitors: A Nationwide Danish Study.” European Heart Journal, vol. 42, no. 16, Apr. 2021, pp. 1621–31. EBSCOhost, https://doi.org/10.1093/eurheartj/ehaa884.

APA

D’Souza, M., Nielsen, D., Svane, I. M., Iversen, K., Rasmussen, P. V., Madelaire, C., Fosbøl, E., Køber, L., Gustafsson, F., Andersson, C., Gislason, G., Torp-Pedersen, C., & Schou, M. (2021). The risk of cardiac events in patients receiving immune checkpoint inhibitors: a nationwide Danish study. European Heart Journal, 42(16), 1621–1631. https://doi.org/10.1093/eurheartj/ehaa884

Chicago

D’Souza, Maria, Dorte Nielsen, Inge Marie Svane, Kasper Iversen, Peter Vibe Rasmussen, Christian Madelaire, Emil Fosbøl, et al. 2021. “The Risk of Cardiac Events in Patients Receiving Immune Checkpoint Inhibitors: A Nationwide Danish Study.” European Heart Journal 42 (16): 1621–31. doi:10.1093/eurheartj/ehaa884.